Doctors Quality Reporting Network

A Qualified Clinical Data Registry (QCDR) is a CMS-approved entity that collects clinical data on behalf of clinicians for data submission. By achieving registry status, the Doctors Quality Reporting Network (DQRN) marries the collection of patient data and the submission of data in one entity for physicians. The DQRN currently submits National Committee for Quality Assurance (NCQA) and ONC certified electronic clinical quality measures (eCQMs), Promoting Interoperability (PI) and Improvement Activities (IA) to CMS. These measures are standardized and intended to provide reliable indicators of high quality patient care. The metrics cover management of chronic diseases, preventive care screening, use of appropriate medications, use of electronic medical records, patient engagement and overall cost of care reductions.

Physicians and clinicians across the nation have a trusted choice when reporting key components of the Merit-Based Incentive Payment System (MIPS) as a part of the Centers for Medicare and Medicaid Services’ (CMS) Quality Payment Program (QPP). To view the Quality Measure Specifications, visit this CMS Resource page and scroll to the sub-head "Quality". To view a complete list of the 2018 Qualified Clinical Data Registries for the Merit-based Incentive Payment System (MIPS), visit this CMS Resource page and scroll to the sub-head "Vendors". Choose the first bulleted item, "Qualified Clinical Data Registries (QCDRs) Qualified Posting" and download the Excel file.

To utilize the DQRN, physicians and clinicians must be participating members in the Kansas Health Information Network.

KHIN Member Individual reporting rate: $250 per clinician per year; KHIN Member Group reporting rate: $250 per clinician per year, up to a maximum of $1000 per group per year.

Individual MIPS Eligible Clinicians, Groups, Virtual Groups

The Doctors Quality Reporting Network seamlessly extracts, aggregates, calculates and reports MIPS measures for individual physicians and groups. DQRN analytics and reporting includes QPP Quality measures, as well as promoting Interoperability and Advancing Care Information attestation. DQRN staff provide clinicians with assistance in the selection of measures to be reported and physician developed dashboards provide actionable information to assist in meeting quality metrics and improvement activities.

Promoting Interoperability, Improvement Activities, Quality

  • Care transition standard operational improvements
  • Chronic care and preventative care management for empaneled patients
  • Engagement of community for health status improvement
  • Engagement of patients through implementation of improvements in patient portal
  • Implementation of formal quality improvement methods, practice changes or other practice improvement processes
  • Implementation of methodologies for improvements in longitudinal care management for high risk patients
  • Measurement and improvement at the practice and panel level
  • Participation in a QCDR, that promotes use of patient engagement tools.
  • Population empanelment
  • Practice improvements for bilateral exchange of patient information
  • Practice improvements that engage community resources to support patient health goals
  • Regular review practices in place on targeted patient population needs
  • Use of QCDR data for quality improvement such as comparative analysis reports across patient populations
  • Use of QCDR for feedback reports that incorporate population health
  • Use of QCDR patient experience data to inform and advance improvements in beneficiary engagement.
  • Care coordination agreements that promote improvements in patient tracking across settings
  • Implementation of condition-specific chronic disease self-management support programs
  • Implementation of improvements that contribute to more timely communication of test results
  • Implementation of medication management practice improvements
  • Improved practices that disseminate appropriate self-management materials
  • Leadership engagement in regular guidance and demonstrated commitment for implementing practice improvement changes
  • Participation in population health research
  • Use of QCDR data for ongoing practice assessment and improvements
  • Use of QCDR to promote standard practices, tools and processes in practice for improvement in care coordination
  • Send a Summary of Care
  • Provide Patient Access
  • e-Prescribing
  • Security Risk Analysis
  • Request/Accept Summary of Care
  • Patient-Generated Health Data
  • Secure Messaging
  • View, Download and Transmit (VDT)
  • Clinical Information Reconciliation
  • Patient-Specific Education
  • Immunization Registry Reporting
  • Clinical Data Registry Reporting
  • Public Health Registry Reporting
  • Syndromic Surveillance Reporting
  • Electronic Case Reporting
  • CMS2 Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
  • CMS50 Closing the Referral Loop: Receipt of Specialist Report
  • CMS65 Hypertension: Improvement in Blood Pressure (Intermediate Outcome)
  • CMS68 Documentation of Current Medications in the Medical Record
  • CMS69 Preventive Care and Screening: Body Mass Index Screening and Follow-Up Plan
  • CMS74 Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
  • CMS82 Maternal Depression Screening
  • CMS90 Functional Status Assessments for Congestive Heart Failure
  • CMS117 Childhood Immunization Status
  • CMS122 Diabetes: Hemoglobin A1c Poor Control
  • CMS123 Diabetes: Foot Exam
  • CMS124 Cervical Cancer Screening
  • CMS125 Breast Cancer Screening
  • CMS127 Pneumonia Vaccination Status for Older Adults
  • CMS128 Anti-Depressant Medication Management
  • CMS130 Colorectal Cancer Screening
  • CMS131 Diabetes: Eye Exam
  • CMS134 Diabetes: Urine Protein Screening
  • CMS135 Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction
  • CMS136 ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
  • CMS137 Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
  • CMS138 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • CMS139 Falls: Screening for Future Fall Risk
  • CMS144 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction
  • CMS145 Coronary Artery Disease: Beta-Blocker Therapy—Prior Myocardial Infarction or Left Ventricular Systolic Dysfunction (LVEF <40%)
  • CMS146 Appropriate Testing for Children with Pharyngitis
  • CMS147 Preventive Care and Screening: Influenza Immunization
  • CMS149 Dementia: Cognitive Assessment
  • CMS153 Chlamydia Screening for Women
  • CMS154 Appropriate Treatment for Children with Upper Respiratory Infection (URI)
  • CMS155 Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
  • CMS156 Use of High-Risk Medications in the Elderly
  • CMS159 Depression Remission at Twelve Months
  • CMS160 Depression Utilization of the PHQ-9 Tool
  • CMS164 Ischemic Vascular Disease: Use of Aspirin or Another Antiplatelet
  • CMS165 Controlling High Blood Pressure
  • CMS2 Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
  • CMS50 Closing the Referral Loop: Receipt of Specialist Report
  • CMS65 Hypertension: Improvement in Blood Pressure (Intermediate Outcome)
  • CMS68 Documentation of Current Medications in the Medical Record
  • CMS69 Preventive Care and Screening: Body Mass Index Screening and Follow-Up Plan
  • CMS74 Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
  • CMS82 Maternal Depression Screening
  • CMS90 Functional Status Assessments for Congestive Heart Failure
  • CMS117 Childhood Immunization Status
  • CMS122 Diabetes: Hemoglobin A1c Poor Control
  • CMS123 Diabetes: Foot Exam
  • CMS124 Cervical Cancer Screening
  • CMS125 Breast Cancer Screening
  • CMS127 Pneumonia Vaccination Status for Older Adults
  • CMS128 Anti-Depressant Medication Management
  • CMS130 Colorectal Cancer Screening
  • CMS131 Diabetes: Eye Exam
  • CMS134 Diabetes: Urine Protein Screening
  • CMS135 Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction
  • CMS136 ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication
  • CMS137 Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
  • CMS138 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • CMS139 Falls: Screening for Future Fall Risk
  • CMS144 Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction
  • CMS145 Coronary Artery Disease: Beta-Blocker Therapy—Prior Myocardial Infarction or Left Ventricular Systolic Dysfunction (LVEF <40%)
  • CMS146 Appropriate Testing for Children with Pharyngitis
  • CMS147 Preventive Care and Screening: Influenza Immunization
  • CMS149 Dementia: Cognitive Assessment
  • CMS153 Chlamydia Screening for Women
  • CMS154 Appropriate Treatment for Children with Upper Respiratory Infection (URI)
  • CMS155 Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
  • CMS156 Use of High-Risk Medications in the Elderly
  • CMS159 Depression Remission at Twelve Months
  • CMS160 Depression Utilization of the PHQ-9 Tool
  • CMS164 Ischemic Vascular Disease: Use of Aspirin or Another Antiplatelet
  • CMS165 Controlling High Blood Pressure

 

Download the PDF version here.

Disclaimer: Each vendor has reviewed their organization’s information and provided confirmation of accuracy. Information included in this document was accurate at the time of posting; however, CMS cannot guarantee that these services will be available or that the vendor will be successful uploading their files during the submission period. CMS cannot guarantee an eligible clinicians success in providing data for the program. Successful submission is contingent upon following the MIPS program requirements: the timeliness, quality, and accuracy of the data provided for reporting by the eligible clinician, group, and/or virtual group, and the timeliness, quality, and accuracy of the vendor.